Vivos Therapeutics (VVOS) Q2 2026 Earnings

May 20Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.55
-0.49
-0.44
-0.38

Details

Expected EPS
-0.453333
Actual EPS
-0.52
Surprise EPS
-0.07
Surprise Percent
-14.71%

Description

⁨Vivos Therapeutics⁩ (⁦VVOS⁩) has reported earnings of ⁦-0.52⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts